Flamel Technologies Announces Licensing Agreement with Pfizer Inc.

Full story: BioSpace

Flamel Technologies today announced that Pfizer has exercised its option to license Flamela s MedusaA technology for the development of a controlled release formulation of an already-marketed therapeutic protein.

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Wyeth Discussions

Topic	Updated	Last By	Comments
As Layoffs Begin, Wyeth Execs Get $75 Million S... (Feb '09)	9 hr	Anonymous	2
Wyeth: Ghostwritten Papers Fake, But Accurate	Jul '09	Jeremiah	1
Wyeth's Pristiq, a New Treatment for Major Depr... (Jul '08)	Jul '09	Tetelestai	5
ativan untill 2003 Wyeth product (Feb '08)	May '09	patient aol	6
Taking Advantage of Biotech Sector with ETFs (Jan '09)	Jan '09	dollarbill	1
Pfizer is in talks to acquire Wyeth for $60B, r... (Jan '09)	Jan '09	History Buff	1
Zacks Analyst Blog Highlights: Wyeth, Advance A... (Dec '08)	Dec '08	Upper Strut ...	1